​

Dr. A. Kharlamov has 27 years of clinical experience in cardiology (since 1996; a Consultant Physician since 2007, a Board-Certified [by the graduate course] Cardiologist since 2010), some experience in bench-to-bedside studies in interventional cardiology (a leader of the research group since 2007) including academic research in imaging, vascular biology, and pathology, RTD of cardiovascular imaging software (artificial intelligence/ machine learning), medical devices (bioresorbable scaffolds and stents, nanotechnology). He received his M.D. (Doctor of Medicine) cum laude in 2005 from Ural State Medical University (Yekaterinburg, Russia). After finishing his internship in internal medicine in 2007 at the Ural Institute of Cardiology (Yekaterinburg, Russia), he started as a physician and a researcher. He passed his C.Sc.-doctoral/ graduate degree course in cardiology (A.B.D.) at the Ural State Medical University in 2008-2011. From 2007 to 2009, he worked as a research fellow in some institutions in the Netherlands (UMC St Radboud, Nijmegen; UMCG, Groningen; Erasmus MC, Rotterdam). He is an author of more than 60 articles and grant proposals for the European Commission and has received some national and international awards for his research work. Since Dec 2018 he is a FESC, and Jan 2019 - a FACC, Jan 2020 - a FEACVI.

​

Publications:
h-index = 9. The publication profile is available in PubMed (akharlamov@orcid), ORCiD (0000-0003-4631-1261), ResearcherID/ Web of Science (I-3692-2015), and Scopus (56721449700). The editorial/ reviewer profile (Local editorial board member in EuroIntervention in 2011-2013, member of the International Editorial Board in European Heart Journal in 2013-2015, consulting editor in both Cardiovascular Diagnosis and Therapy in 2013-2017, and International Journal of Nanomedicine in 2013-2019), member of the Editorial Board in World Journal of Cardiology (in 2018-2023) and BMC: Cardiovascular Disorders (since 2020) is available in Publons/ Web of Science (publons.com/a/1136995/). We do not collaborate with ResearchGate.

​

Memberships:
European Society of Cardiology - ESC (since 2006; FESC since 2018; FEACVI since 2020; a Treasurer of the ESC Council for Cardiology Practice with a mandate in 2022-2024), American College of Cardiology - ACC (since 2009; FACC since 2019), American Heart Association - AHA (since 2009), International Society for Stem Cell Research - ISSCR (since 2009), International Society of Nephrology - ISN (since 2009), European Society for Nanomedicine - ESNM (since 2011), The Society for Cardiovascular Angiography and Interventions - SCAI (since 2017), World Sleep Society - WSS (since 2018), The British Society for Nanomedicine - BSN (since 2018), Royal College of Physicians of London - RCP (since 2019), International Society for Cardiovascular Translational Research - ISCTR (since 2019), American Association for the Advancement of Science - AAAS (since 2019), Society of Cardiovascular Computed Tomography - SCCT (since 2019).